Synthetic peptide significantly enhances the only currently approved drug to get blood flow moving to the brain after a stroke.
An Israeli pharma company is testing an advanced compound that blocks a tumor’s blood supply. Used with standard chemo, it obliterates the growth.
A new Israeli study shows that with support from the supervisor, a stressed employee is less likely to need days off to recover.
Bold new three-year collaboration gives the global pharma giant access to the Weizmann Institute’s bright ideas in medical treatment and diagnosis.
A simple bedside test to be available soon in Europe may be the most potent weapon against hospital-borne infection to date.
The first Israeli study of its kind finds 90% of active firefighters exhibit symptoms of post-traumatic stress disorder, and suggests how to improve the numbers.
Israeli university researchers unveil their discovery of a gene that increases the lifespan of lab animals, and perhaps of humans too.
The simple new check shows a 90 percent detection rate in clinical tests for multiple types of cancers.
Israeli company’s LiteTouch laser system is becoming a fast favorite of dentists and their patients in the US, Asia and Europe.